Posts Tagged ‘drug importation’
Canadians assure their peers: Importation isn’t a threat to our drug supply because it isn’t viable
This editorial by David C. Rosenbaum and Dara Jospé was published in the Financial Post on January 16, 2020. Rosenbaum is a partner of the law firm Fasken. Jospé is an associate for the same company.
[...]Academic Warns That State Drug Importation Proposals Threaten Patients and Innovation
This editorial by Dr. Kristina M. L. Acri née Lybecker was published in IP Watchdog on January 2, 2020. Dr. Acri is an Associate Professor of Economics at Colorado College in Colorado Springs, and Chair of the Department of Economics and Business.
[...]Canadian Doctors, Pharmacists, Patient Groups and Government Representatives Consider State Importation Proposals Unfeasible
In spite of recent efforts by legislators in Florida, Maine, Colorado, and elsewhere, Canadian patient groups are vocally opposing pending legislation that proposes importing prescription medications from the Canadian drug supply. Paul Blanchard of the New Brunswick Pharmacists’ Association told CBC News, “The country’s pharmacists association has been talking to the federal government … to make sure that the federal government and Canada is aware that the Americans are literally knocking on our door.”
[...]Two Studies Confirm Drug Importation Would Decimate The Canadian Drug Supply
Two new studies recently published in Canadian Health Policy each reached the same conclusion: legalizing drug importation in the U.S. would cause catastrophic damage to the Canadian drug supply…
[...]Pharmacy professor: buying prescription drugs from Canada “risky in terms of quality and safety”
This editorial by C. Michael White was published in The Conversation on September 27, 2019. White is a professor and head of the Department of Pharmacy Practice for the University of Connecticut.
[...]Partnership for Safe Medicines 2019 Congressional Briefings (September 24, 2019)
On Tuesday, September 24, 2019, counterfeit medication victims and their families, American and Canadian patient groups, local and federal law enforcement, and other experts in the fight against counterfeit medicines gathered in Washington, D.C. to discuss how importation proposals threaten to trigger drug shortages in Canada while wreaking havoc on medication safety for U.S. patients.
[...]Former FDA Associate Commissioner Says Canada Cannot Be America’s Pharmacy
This editorial by Peter J. Pitts was published in The Washington Times on September 11, 2019. Mr. Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner.
[...]Economic Policy Researcher Finds Fault with Federal Drug Importation Plans
This editorial by Liam Sigaud was published by Inside Sources on August 27, 2019. Mr. Sigaud is an economic policy researcher who writes for the American Consumer Institute, a nonprofit educational and research organization.
[...]Drug Importation By the Numbers
When broken down to the nuts and bolts of implementation and operational execution, current drug importation plans fall apart. Drug Importation is neither a safe nor cost-effective solution. The numbers do not lie.
[...]Economist Demonstrates That U.S. Drug Importation Would Endanger Canada’s Prescription Medication Supply
This editorial by Fergus Hodgson was published in the Epoch Times on August 14, 2019. Mr. Hodgson is an independent economic consultant, and Executive Editor of the Antigua Report.
[...]